Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1022 participants.

Also called NCT06025123

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,022 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06025123
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Belgium, Germany, Italy, Norway, Slovenia, Spain, Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06025123. Randomized; double masking; primary purpose treatment. Start 2024-03-27 (actual); primary completion 2028-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2
Acronym
PRINCESS2
Condition
Out-Of-Hospital Cardiac Arrest
Condition
Hypothermia
Intervention (Device)
Early transnasal evaporative cooling with the RhinoChill device
Lead sponsor
Karolinska Institutet (class: other)

Record details

Record id
cardio:ct-nct06025123
Content hash
ed5641cfca3cbc9671349b7f00edd50045ad44e317410dda4ccf2a8cb0d4ab1f